Clinical Pharmacology · Emergency and Critical Care Medications
Sepsis Medications
On this page 6 sections
In 30 seconds
Sepsis is a life-threatening reaction to infection in which the body's own inflammatory response injures blood vessels and organs rather than containing the pathogen. Management is a race against time: draw cultures, start broad-spectrum antibiotics without delay, give fluids to restore circulating volume, and add a vasopressor — norepinephrine first — when perfusion does not recover. Septic shock is the more severe stage, defined by the need for vasopressors to maintain blood pressure alongside evidence that cells are not getting enough oxygen. Nurses are often first to notice the warning signs and the ones who make sure antibiotics and fluids move fast enough to matter.
The college version
Pathophysiology in brief
Sepsis begins when the immune response to infection stops being protective and becomes destructive. Mediators released to fight the pathogen also dilate blood vessels, make capillary walls leaky, and trigger small clots throughout the microcirculation. The result is a drop in effective circulating volume, poor oxygen delivery to tissues, and progressive organ dysfunction affecting kidneys, lungs, liver, and brain. Septic shock is distinguished from sepsis by two features: a vasopressor is required to sustain adequate blood pressure despite fluid resuscitation, and there is biochemical evidence — an elevated blood marker of cellular stress — that tissues are under significant metabolic strain. This marker is measured at presentation and rechecked; a falling level suggests treatment is improving perfusion.
The time-critical bundle
When sepsis is suspected, several actions happen in close sequence. Blood cultures are drawn first whenever this will not meaningfully delay antibiotics, since identifying the organism later guides de-escalation. Broad-spectrum antibiotics follow urgently — delay in effective antibiotic therapy is one of the most consistent predictors of worse outcomes in septic shock, so "antibiotics now" is treated as a true emergency task. Empiric antibiotic choice is guided by the suspected source of infection, the patient's individual risk factors, and local resistance patterns, including whether coverage for resistant organisms such as MRSA or Pseudomonas is warranted. Once culture results return, therapy is de-escalated to a narrower agent to limit resistance pressure and adverse effects. Crystalloid fluids are given promptly to restore intravascular volume, with balanced solutions generally favored over plain normal saline because large-volume saline is linked to electrolyte disturbance and kidney stress. Fluid administration is not unlimited: the modern approach favors starting a vasopressor early once fluids alone are clearly not restoring perfusion, rather than pushing ever more volume, which risks pulmonary edema and worsened capillary leak.
Vasopressors and adjunctive therapy
Norepinephrine is first-line for septic shock because it reliably raises blood pressure through vasoconstriction with modest effects on heart rate. Vasopressin is commonly added to reduce the norepinephrine dose needed, and epinephrine may be added when pressure remains inadequate. For shock refractory to fluids and escalating vasopressors, corticosteroids address relative adrenal insufficiency and dampen inflammation. Source control — draining an abscess, removing an infected device, or surgically addressing a perforated organ — is essential and cannot be replaced by medication; antibiotics alone cannot clear an undrained infection.
Therapies that did not hold up
Sepsis research includes notable disappointments. Activated protein C, once approved as an anti-inflammatory, anticoagulant therapy for severe sepsis, was withdrawn after later trials failed to confirm survival benefit and showed bleeding risk. The combination of intravenous vitamin C, thiamine, and hydrocortisone drew enthusiasm as a potential mortality-reducing therapy, but larger, better-controlled trials have not confirmed meaningful benefit, and it is not standard care. These histories show how promising early results in critical care can fail to replicate in rigorous trials.
Supportive care and the nursing role
Supportive measures reduce complications during critical illness: glucose control avoids harm from both very high and very low blood sugar, prophylaxis against venous thromboembolism and stress ulceration is routine in immobilized patients, and lung-protective ventilation limits added lung injury during mechanical ventilation. None replace source control or antibiotics, but each reduces secondary morbidity. Nurses are frequently positioned to catch sepsis early through vigilant assessment — altered mental status, rising respiratory rate, cool or mottled skin, falling urine output. Once sepsis is suspected, nurses drive the bundle's urgency: obtaining cultures quickly, ensuring antibiotics are given without delay, monitoring fluid response, and watching perfusion closely as vasopressors are titrated.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your body has a security team that fights germs. Normally it's careful and only attacks invaders. In sepsis, the security team panics and starts causing damage everywhere — it makes blood vessels leaky like a hose full of tiny holes, so pressure drops and organs stop getting enough oxygen and food. The care team races to fix this: they take a blood sample to identify the germ, give strong infection-fighting medicine fast, and pour in fluids like refilling a leaky pool. If the pool still won't stay full, they give a vasopressor that squeezes the vessels a bit, like pinching the holes in the hose so pressure builds back up. If a hidden pocket of infection exists, like a splinter causing trouble, it must be removed directly — medicine alone can't do that part.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with septic shock has already received substantial crystalloid fluids but remains hypotensive with poor perfusion. What is the generally preferred next step rather than continuing large-volume fluids alone?
Show answer
Starting a vasopressor
Rather than pouring in more fluid, the modern approach starts a vasopressor earlier to support blood pressure directly, since excess fluid can leak into tissues and worsen lung function without fixing the underlying problem.
Why was activated protein C withdrawn from clinical use, and what lesson does this offer about adjunctive sepsis therapies in general?
Show answer
It didn't save more lives, and it caused bleeding
Later, more careful studies showed activated protein C did not improve survival as first hoped and increased bleeding risk, so it was pulled from the market. This shows that hopeful early results in sepsis therapy must be confirmed by rigorous trials before becoming standard care, since other adjunctive treatments have similarly failed to hold up.
Quick check
3 questions here. Answers stay hidden until you check.
Why are blood cultures usually drawn before antibiotics, when possible?
Which vasopressor is considered first-line in septic shock?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

